Scarica l'app Stockscreener
1.41
1.44%
0.02
Dopo l'orario di chiusura:
1.44
0.03
+2.13%
Precedente Chiudi:
$1.39
Aprire:
$1.4
Volume 24 ore:
86,813
Relative Volume:
0.04
Capitalizzazione di mercato:
$15.95M
Reddito:
$23.28M
Utile/perdita netta:
$-23.75M
Rapporto P/E:
-0.4623
EPS:
-3.05
Flusso di cassa netto:
$-25.22M
1 W Prestazione:
-6.00%
1M Prestazione:
-16.57%
6M Prestazione:
-37.05%
1 anno Prestazione:
-70.44%
Intervallo 1D:
$1.3701
$1.435
Intervallo di 1 settimana:
$1.36
$1.528
Portata 52W:
$1.22
$5.28
Lifeward Ltd Stock (LFWD) Company Profile
Nome
Lifeward Ltd
Settore
Industria
Telefono
15082511154
Indirizzo
200 DONALD LYNCH BLVD., MARLBOROUGH
Confronta LFWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
1.41 | 15.95M | 23.28M | -23.75M | -25.22M | -3.05 |
|
ABT
Abbott Laboratories
|
132.82 | 223.47B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.93 | 150.72B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
378.22 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.85 | 107.15B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.65 | 44.54B | 5.54B | 4.18B | 259.90M | 7.00 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Iniziato | Laidlaw | Buy |
| 2017-04-03 | Downgrade | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Iniziato | Oppenheimer | Outperform |
| 2016-07-15 | Iniziato | Piper Jaffray | Overweight |
| 2015-05-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Reiterato | Barclays | Equal Weight |
| 2014-10-07 | Iniziato | Barclays | Equal Weight |
Mostra tutto
Lifeward Ltd Borsa (LFWD) Ultime notizie
Lifeward (LFWD) Secures Insurance Approval for ReWalk 7 Exoskele - GuruFocus
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton - GlobeNewswire
Major Insurance Breakthrough: ReWalk 7 Exoskeleton Gets Historic First Commercial Coverage - Stock Titan
Lifeward Ltd. Reports Third Quarter 2024 Financial Results - ADVFN
Israeli Soldier Becomes First War Casualty to Use ReWalk Exoskeleton (LFWD) | LFWD Stock News - GuruFocus
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Per - GuruFocus
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton - The Manila Times
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton | LFWD Stock News - GuruFocus
Revolutionary ReWalk Exoskeleton Helps Paralyzed Israeli Soldier Walk: Military Healthcare Breakthrough - Stock Titan
Lifeward launches sales of ReWalk 7 personal exoskeleton in U.S. - MSN
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 - MSN
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients By Investing.com - Investing.com South Africa
Lifeward (LFWD) Launches ReWalk 7 Exoskeleton in the U.S., Shares Rise - GuruFocus
Lifeward (LFWD) Launches Next-Gen ReWalk 7 Personal Exoskeleton Nationwide | LFWD Stock News - GuruFocus
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients - Investing.com Australia
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market | LFWD Stock News - GuruFocus
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market - The Manila Times
Lifeward Ltd. reports preliminary Q1 financial results - Investing.com Australia
Lifeward Ltd. reports preliminary Q1 financial results By Investing.com - Investing.com Canada
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges - Investing.com Australia
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Lifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton - TradingView
Lifeward gains FDA clearance for new ReWalk exoskeleton - Investing.com
Sector Update: Health Care Stocks Softer Thursday Afternoon -March 13, 2025 at 02:06 pm EDT - Marketscreener.com
Sector Update: Health Care -March 13, 2025 at 01:43 pm EDT - Marketscreener.com
What's Going On With Lifeward Shares Thursday?Lifeward (NASDAQ:LFWD) - Benzinga
FDA Approval of ReWalk7 Sends Lifeward (LFWD) Stock Climbing - Stocks Telegraph
Lifeward announces FDA clearance for ReWalk 7 exoskeleton - TipRanks
Lifeward Receives FDA Clearance for ReWalk 7 Exoskeleton; Shares Jump -March 13, 2025 at 09:41 am EDT - Marketscreener.com
Lifeward gains FDA clearance for new ReWalk exoskeleton By Investing.com - Investing.com UK
FDA Issues Clearance for ReWalk 7 Exoskeleton - GlobeNewswire
Revolutionary ReWalk 7 Exoskeleton Gets FDA Green Light, Medicare Coverage Ready - StockTitan
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright - Investing.com Australia
Positive Outlook for Lifeward Driven by Strategic Partnerships and Market Expansion Initiatives - TipRanks
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright By Investing.com - Investing.com South Africa
Lifeward Ltd Azioni (LFWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lifeward Ltd Azioni (LFWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lind Global Fund II LP | 10% Owner |
Jan 07 '25 |
Sale |
1.94 |
191,434 |
371,907 |
857,996 |
| Richner Randel | Director |
Dec 13 '24 |
Sale |
1.68 |
4,285 |
7,214 |
0 |
| Turk Joseph E Jr | Director |
Dec 13 '24 |
Buy |
1.69 |
6,000 |
10,140 |
18,516 |
| Swinford Michael | Director |
Nov 25 '24 |
Buy |
2.03 |
21,622 |
43,858 |
65,040 |
| Swinford Michael | Director |
Nov 22 '24 |
Buy |
1.83 |
16,907 |
30,899 |
43,418 |
| Swinford Michael | Director |
Nov 20 '24 |
Buy |
1.84 |
16,471 |
30,231 |
26,511 |
| Jasinski Lawrence J | Chief Executive Officer |
Sep 13 '24 |
Sale |
3.26 |
2,672 |
8,700 |
100,637 |
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):